**Chart Analysis: Expenses as a Percentage of Revenue (Meta)**

**Metric Measured:** Expenses as a percentage of revenue, categorized into Cost of Revenue, Research & Development, Marketing & Sales, and General & Administrative, across nine quarters from Q2'23 to Q2'25.

**Key Data Points and Values:**

*   **Q2'23:** Cost of Revenue: 19%, Research & Development: 29%, Marketing & Sales: 10%, General & Administrative: 13%. Total: 71%.
*   **Q3'23:** Cost of Revenue: 18%, Research & Development: 27%, Marketing & Sales: 8%, General & Administrative: 6%. Total: 59%.
*   **Q4'23:** Cost of Revenue: 19%, Research & Development: 26%, Marketing & Sales: 8%, General & Administrative: 6%. Total: 59%.
*   **Q1'24:** Cost of Revenue: 18%, Research & Development: 27%, Marketing & Sales: 7%, General & Administrative: 9%. Total: 61%.
*   **Q2'24:** Cost of Revenue: 19%, Research & Development: 27%, Marketing & Sales: 7%, General & Administrative: 9%. Total: 62%.
*   **Q3'24:** Cost of Revenue: 18%, Research & Development: 28%, Marketing & Sales: 7%, General & Administrative: 5%. Total: 58%.
*   **Q4'24:** Cost of Revenue: 18%, Research & Development: 25%, Marketing & Sales: 7%, General & Administrative: 2%. Total: 52%.
*   **Q1'25:** Cost of Revenue: 18%, Research & Development: 29%, Marketing & Sales: 7%, General & Administrative: 5%. Total: 59%.
*   **Q2'25:** Cost of Revenue: 18%, Research & Development: 27%, Marketing & Sales: 6%, General & Administrative: 6%. Total: 57%.

**Significant Trends:**

*   **Overall Expense Reduction:** Total expenses as a percentage of revenue significantly decreased from 71% in Q2'23 to 57% in Q2'25, with a low point of 52% in Q4'24.
*   **General & Administrative (G&A):** Showed the most dramatic reduction, falling from 13% in Q2'23 to 6% in Q3'23. It fluctuated, hitting a low of 2% in Q4'24, before settling at 6% in Q2'25.
*   **Marketing & Sales:** Decreased from 10% in Q2'23 to 8% by Q3'23, then stabilized at 7% from Q1'24 to Q1'25, ending at 6% in Q2'25.
*   **Cost of Revenue:** Remained relatively stable, consistently between 18% and 19% throughout the period.
*   **Research & Development (R&D):** Fluctuated between 25% and 29%, generally remaining the largest expense category. It decreased from 29% in Q2'23 to 25% in Q4'24, then rose to 29% in Q1'25 before ending at 27% in Q2'25.